Fresenuis Medical Care Central Tampa, FL - 33634

Fresenuis Medical Care Central is categorized under Health Information and Referral Programs in Tampa, FL .

Fresenuis Medical Care Central was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Health Information and Referral Programs business, which does work in the B2C market, and is classified as a Health Information and Referral Programs, under code number by the NAICS.

If you are seeking more information, feel free to contact Kendra Echols at the company’s single location by writing to 5625 W Waters Avenue # A, Tampa, Florida FL 33634 or by phoning (813) 880-8611. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Fresenuis Medical Care Central
Contact Person: Kendra Echols
Address: 5625 W Waters Avenue # A, Tampa, Florida 33634
Phone Number: (813) 880-8611
Annual Revenue (USD): $2.500.000 to $4.999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Health Information and Referral Programs
Share This Business:

Fresenuis Medical Care Central was started in 0 to provide professional Health Information and Referral Programs under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Kendra Echols for inquiries that concern Fresenuis Medical Care Central by calling the company number (813) 880-8611, as your correspondence is most welcome. Additionally, the physical location of the single location of Fresenuis Medical Care Central can be found at the coordinates 28.02556,-82.5387 as well as the street address 5625 W Waters Avenue # A in Tampa, Florida 33634.

For its online presence, you may visit Fresenuis Medical Care Central’s website at and engage with its social media outlets through on Twitter and on Facebook.